5+ day, 4+ hour ago   (368+ words) BiotechDispatch Australia secures sovereign viral vector manufacturing as VVMF wins TGA licence A Sydney company has become the first in Australia to earn a manufacturing licence for viral vectors, a milestone it says strengthens the nation's capacity to make advanced…...

1+ week, 11+ hour ago   (412+ words) BiotechDispatch Arovella Therapeutics moves 'off-the-shelf' cell therapy from lab to patients Arovella Therapeutics has taken a step toward treating blood cancer patients with donor-derived cells rather than their own, announcing that it has released its first clinical manufacturing batch of…...

1+ week, 11+ hour ago   (359+ words) BiotechDispatch Australian biotech Immuron takes gut health treatment to the US market Melbourne-based Immuron is preparing to bring its digestive health product PROIBS to American shelves after striking an exclusive distribution deal with Swedish life science company Calmino Group AB....

1+ week, 11+ hour ago   (504+ words) BiotechDispatch Neurizon Therapeutics appoints Chris Bremer as chief executive to steer ALS drug through final trial stage Neurizon Therapeutics, the Melbourne-based biotechnology company developing a treatment for the fatal neurological disease ALS, has appointed Dr Chris Bremer as its new…...

2+ week, 9+ hour ago   (279+ words) Alterity Therapeutics has secured an underwriting agreement that could provide at least $4.2 million in additional funding as the company prepares to begin its planned Phase 3 clinical trial of ATH434 in multiple system atrophy. The Melbourne- and San Francisco-based biotechnology company said…...

2+ week, 6+ day ago   (394+ words) Nanosonics has entered financial year 2027 with continued growth from its trophon disinfection business, while advancing the commercial rollout of its CORIS endoscope reprocessing platform and commencing a new on-market share buyback of up to $40 million. Revenue rose 3 per cent to…...

2+ week, 6+ day ago   (624+ words) Genetic Signatures has emerged from a year of restructuring with smaller losses, lower cash burn, and a clearer plan to rebuild growth, despite a decline in revenue amid challenging conditions in its core Australian market. The molecular diagnostics company reported…...

2+ week, 6+ day ago   (235+ words) Acrux has appointed physician and biopharmaceutical executive Dr Jolanta Airey as its chief medical officer, strengthening its leadership team as it prepares to advance its female testosterone treatment toward Phase 3 clinical trials in the United States. The Melbourne-based specialty company…...

2+ week, 6+ day ago   (418+ words) Avecho Biotechnology has appointed senior pharmaceutical executive Eve Williamson as a strategic business development consultant, bringing dedicated dealmaking capacity as the company seeks international partners for its CBD TPM soft-gel capsule for insomnia. The appointment comes as Avecho advances its…...

3+ week, 4+ day ago   (252+ words) World-renowned plastic and reconstructive surgeon, Professor Fiona Wood AO, has been announced as the Depaz Orator for the AusBiotech International Conference, held as part of Australia’s Biggest Week in Biotech on the Gold Coast in October 2026. Professor Wood is a…...